Case-Based Roundtable Meetings Spotlight March 2021: Solid Tumors

Similar Outcomes of Multiple Hormonal Agents Give Oncologists Novel Treatment Options for Patients With nmCRPC

April 02, 2021

Clinical Articles

Alicia K. Morgans, MD, MPH, associate professor of Medicine, Feinberg School of Medicine, Northwestern University, reviewed the clinical trial results for multiple hormonal therapies intended to treat prostate cancer. She explained that many of them show similar outcomes.

Multiple Trial Regimens Demonstrate Efficacy for RET-Mutated Medullary Thyroid Cancer

March 31, 2021

Clinical Articles

A number of clinical trials have provided evidence of efficacy of combination regimens for the treatment of RET-mutant medullary thyroid cancer. During a virtual Targeted Oncology Case-based Roundtable event, Lori Wirth, MD, discussed the options for a 58-year-old man with RET-mutant medullary thyroid cancer.

Experts Contemplate Realistic Treatment Goals Using Hedgehog Inhibitors in Basal Cell Carcinoma

March 26, 2021

Clinical Articles

Hedgehog inhibitors are becoming more widely used for Basal cell carcinoma. Two experts, Shailender Bhatia, MD and Paul T. Nghiem, MD, PhD discussed the reality of hedgehog inhibitor use in practice during a virtual Targeted Oncology Case-Based Roundtable event.